Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Oct 9, 2024
- Accession no.
- 0001447362-24-000158
- Filed
- Oct 9, 2024
- Trade date
- Oct 7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $231.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2024 | Common Stock | SSaleDisposed | −5,017 | $29.44F2 | −$147,700.48 | 20,068 | Indirect | |
| Oct 7, 2024 | Common Stock | SSaleDisposed | −1,425 | $29.44F2 | −$41,952 | 5,700 | Indirect | |
| Oct 7, 2024 | Common Stock | SSaleDisposed | −1,425 | $29.44F2 | −$41,952 | 5,700 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $29.18 to $29.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.